Cancer Treatment Centers of America

Atezolizumab (Tecentriq®)

Atezolizumab

Brand name: Tecentriq®

Atezolizumab is approved to treat urothelial carcinoma, the most common type of bladder cancer.

Atezolizumab is a checkpoint inhibitor, an immunotherapy drug designed to target the PD-L1 protein on cancer cells. Cancer cells are able to use PD-L1 to send signals to the PD-1 protein on immune cells, tricking the immune cells into recognizing the cancer cells as normal. Atezolizumab is designed to block those signals and expose the cancer cells to the immune system.

Atezolizumab is given intravenously over a 60-minute period, usually every three weeks. The dosage and frequency depend on how the cancer responds to the therapy and the severity of side effects you may be experiencing.

Atezolizumab side effects

Before taking atezolizumab, tell your doctor if you have an auto-immune condition such as Crohn’s disease or colitis. You should also tell your doctor if you have had an organ transplant, lung or breathing problems, liver problems or any other serious medical issues. Atezolizumab travels through the bloodstream, so tell your doctor if you are nursing, pregnant or plan to become pregnant. You should also inform your doctor about any drugs or nutritional supplements you are taking.

Because atezolizumab helps prompt an immune response, T-cells may attack healthy cells in addition to malignant cells, triggering an auto-immune reaction.

The most common side effects of atezolizumab include:

  • Fatigue
  • Decreased appetite
  • Fever
  • Constipation
  • Nausea
  • Urinary tract infection
  • Fever

Your care team at Cancer Treatment Centers of America® (CTCA) will explain the side effects of nivolumab, help you determine whether you are a candidate for the drug and recommend a treatment plan tailored to your needs.

Atezolizumab for cancer treatment

Atezolizumab is used to treat:

  • Bladder cancer
At Cancer Treatment Centers of America® (CTCA), we are committed to delivering innovative treatment options to our patients as soon as possible. Atezolizumab is not an option for every patient. Your care team will explore your treatment options and involve you and your family throughout the care plan process, so you are empowerd to make informed decisions about your treatment.

The information provided here is for educational purposes only. In no way should it be considered as offering medical advice. Cancer Treatment Centers of America assumes no responsibility for how this material is used. Please check with a physician if you suspect you are ill. Also note that while Cancer Treatment Centers of America frequently updates its contents, medical information changes rapidly. Therefore, some information may be out of date.